financetom
Business
financetom
/
Business
/
Edison International Q1 Core Earnings Top Consensus View, Revenue Falls, Reiterates In-Line Earnings Forecast
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Edison International Q1 Core Earnings Top Consensus View, Revenue Falls, Reiterates In-Line Earnings Forecast
May 25, 2025 9:13 PM

04:29 PM EDT, 04/29/2025 (MT Newswires) -- Edison International ( EIX ) late Tuesday reported Q1 core earnings of $1.37 per diluted share, up from $1.13 a year earlier.

Analysts polled by FactSet expected EPS of $1.22.

Revenue for the quarter ended March 31 was $3.81 billion, down from $4.08 billion last year.

Analysts expected $4.26 billion.

For 2025, the utility company reiterated its prior forecast expecting core EPS of $5.94 to $6.34. Analysts are looking for $6.05.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Intermap Technologies Files C$100 Million Base Shelf Prospectus
Intermap Technologies Files C$100 Million Base Shelf Prospectus
Sep 17, 2025
07:44 AM EDT, 09/17/2025 (MT Newswires) -- Intermap Technologies ( ITMSF ) , a global player in 3D geospatial products and intelligence solutions, filed overnight Tuesday a final short-form base shelf prospectus with the securities commissions in each of the provinces of Canada, other than Quebec. The company said a corresponding registration statement on Form F-10 was filed with the...
Roivant, Priovant Say Dermatomyositis Treatment Meets Main Goal in Phase 3 Study; Shares up Pre-Bell
Roivant, Priovant Say Dermatomyositis Treatment Meets Main Goal in Phase 3 Study; Shares up Pre-Bell
Sep 17, 2025
07:47 AM EDT, 09/17/2025 (MT Newswires) -- Roivant Sciences ( ROIV ) and Priovant Therapeutics said Wednesday that a phase 3 study of brepocitinib to treat dermatomyositis showed a clinically meaningful and statistically significant improvement, compared with placebo on the primary endpoint and all nine key secondary endpoints. The observed safety profile of a 30-milligram dose was consistent with previous...
IsoEnergy Launches 2025 U.S. Uranium Exploration Program
IsoEnergy Launches 2025 U.S. Uranium Exploration Program
Sep 17, 2025
07:47 AM EDT, 09/17/2025 (MT Newswires) -- IsoEnergy ( ISOU ) said Wednesday that the company is launching its 2025 exploration program in the U.S., focusing on uranium projects in Utah. The program includes the completion of 10 surface rotary holes totaling 15,000 feet on the Flatiron claims located seven miles northwest of the company's past-producing Tony M uranium mine....
Rithm Capital acquires Paramount Group for $1.6 billion
Rithm Capital acquires Paramount Group for $1.6 billion
Sep 17, 2025
Sept 17 (Reuters) - Global asset management company Rithm Capital on Wednesday said it had agreed to acquire real estate investment trust Paramount Group ( PGRE ) for $1.6 billion in cash. (Reporting by Abhinav Parmar in Bengaluru) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved